Super DC cell injection to prevent cancer recurrence after surgery
Part of Cancer clinical trials.
This trial tests a new immune cell treatment called Super DC cells to see if it can stop tumors from coming back after they have been surgically removed. It is for people with solid tumors who have had complete removal of the cancer and show no signs of remaining disease on scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old and weigh at least 40 kg.
- You have a solid tumor that was confirmed by a biopsy and completely removed by surgery.
- After surgery, scans show no remaining cancer, no spread to the brain, and no signs of recurrence.
- You are generally active and able to care for yourself (ECOG score 0 or 1).
- Your heart, liver, kidney, and blood counts are within acceptable ranges as listed in the full criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
This trial tests a new type of immune cell therapy (dendritic cells) that is designed to target specific proteins found on cancer cells. It is for people with certain solid tumors who have already had surgery and at least 4 cycles of standard chemotherapy after surgery.
This trial tests a personalized vaccine designed to train your immune system to fight any remaining cancer cells after surgery or during standard therapy. It is for people with solid tumors who are stable and have no signs of disease getting worse.
This trial tests a new cell therapy, DCTY1102, for people with advanced solid tumors like pancreatic, colorectal, or lung cancer who have tried other treatments. It uses your own immune cells that are modified to target a specific genetic change in your tumor.
This trial tests a personalized cell therapy (tumor polypeptide DC-CTL) for adults with solid tumors such as colorectal, lung, or breast cancer. The goal is to see if infusing your own immune cells trained to attack cancer can help control the disease.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to help your body fight advanced cancer. It is for people whose cancer has not responded to other treatments.
Hear when a new Solid Tumor Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.